Search results for:
empagliflozin
empagliflozin
| Drug Name |
Form |
Strength |
Notes |
| Jardiance |
TABLET, ORAL |
12.5 mg (1/2 of a 25 mg tablet) formulary with restrictions for adults. Pediatrics may use 10 mg tablets (or 1/2 tablet - 5 mg) |
|
Last updated: Jul. 7, 2026
Add Formweb to your mobile device
Formulary Restricted to patients with a diagnosis of heart failure. Exception Unity to support use for DM without HF.
For new starts - The provider or their designee, please check coverage and affordability, by sending a discharge prescription to outpatient pharmacy, in order to ensure continuity of care.
Non-Formulary SGLT2-inhibitors, including empagliflozin 25 mg dose, interchange to empagliflozin 12.5 mg for adults. See Therapeutic Interchange.
Note: for pediatrics, use of 10 mg tablets may continue with the half tablet option (5 mg).